AKT inhibitors promote cell death in cervical cancer through disruption of mTOR signaling and glucose uptake

Background PI3K/AKT pathway alterations are associated with incomplete response to chemoradiation in human cervical cancer. This study was performed to test for mutations in the PI3K pathway and to evaluate the effects of AKT inhibitors on glucose uptake and cell viability.